Results 141 to 150 of about 2,148,029 (249)

Advances of Quantum Key Distribution and Network Nonlocality. [PDF]

Entropy (Basel)
Geng M.
europepmc   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Airborne reflectors for satellite-based quantum entanglement and key distribution. [PDF]

Sci Rep
Sellahewa K, Panigrahy NK, Williams A, Towsley D, Kilbane D.   +4 more
europepmc   +1 more source

Security loophole in error verification in quantum key distribution

Toyohiro Tsurumaru, Akihiro Mizutani, Toshihiko Sasaki   +2 more
openalex   +1 more source

Loophole-free plug-and-play quantum key distribution

, 2021
Ruoyang Qi, Haoran Zhang, Jiancun Gao, Liuguo Yin, Gui‐Lu Long   +4 more
openalex   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Autonomous recognition of erroneous raw key bit bias in quantum key distribution. [PDF]

Sci Rep
Young M, Lucamarini M, Pirandola S.
europepmc   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

A Lightweight Authentication and Key Distribution Protocol for XR Glasses Using PUF and Cloud-Assisted ECC. [PDF]

Sensors (Basel)
Cha W, Lee HJ, Kook S, Kim K, Won D.
europepmc   +1 more source

Continental Shelf Topography: Possible Key to Understanding Distribution of Shelf-Bar Sandstones from Cretaceous Western Interior Seaway: ABSTRACT

, 1983
Roger M. Slatt
openalex   +1 more source